Details for New Drug Application (NDA): 205630
✉ Email this page to a colleague
The generic ingredient in NORGESTIMATE AND ETHINYL ESTRADIOL is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
Summary for 205630
Tradename: | NORGESTIMATE AND ETHINYL ESTRADIOL |
Applicant: | Lupin Ltd |
Ingredient: | ethinyl estradiol; norgestimate |
Patents: | 0 |
Suppliers and Packaging for NDA: 205630
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NORGESTIMATE AND ETHINYL ESTRADIOL | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 205630 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-840 | 68180-840-73 | 3 POUCH in 1 CARTON (68180-840-73) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.035MG;0.25MG | ||||
Approval Date: | Oct 27, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription